PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

For General Information, page-26

  1. dalts66
    4,316 Posts.
    lightbulb Created with Sketch. 2019
    clock Created with Sketch.
    26/01/22
    04:41
    Post #: 59134328
    https://endpts.com/capricor-gets-up-to-735m-for-duchenne-drugs-us-rights-pci-biotech-ends-bile-duct-cancer-clinical-trial/

    This deal was done for a gene therapy treatment thst might work for half the DMD boys. So far the FDA has had problems with most gene therapies, as they cant be proven to work, or they lead to severe response.
    ANP Price at posting: 17.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.